Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Olsen

Showing results (641-650 of 665) with videos related to

Pageof 67
Sort By:
Bioorganic & Medicinal Chemistry Letters|April 9, 2015
Tricyclic 1,5-naphthyridinone oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents-SAR of left-hand-side moiety (Part-2)Sheo B Singh, David E Kaelin, Jin Wu, et al.
JACC. Basic to Translational Science|January 11, 2021
Absence of NLRP3 Inflammasome in Hematopoietic Cells Reduces Adverse Remodeling After Experimental Myocardial InfarctionMieke C Louwe, Maria B Olsen, Ole J Kaasbøll, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2012
MK-5172, a selective inhibitor of hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variantsVincenzo Summa, Steven W Ludmerer, John A McCauley, et al.
Journal of Medicinal Chemistry|February 19, 2010
Discovery of vaniprevir (MK-7009), a macrocyclic hepatitis C virus NS3/4a protease inhibitorJohn A McCauley, Charles J McIntyre, Michael T Rudd, et al.
Iscience|March 29, 2024
T cells with increased responsiveness cause obesity in mice without diet interventionIda Gregersen, Xiang Y Kong, Sander Kooijman, et al.
Cell Reports|January 5, 2017
NEIL3-Dependent Regulation of Cardiac Fibroblast Proliferation Prevents Myocardial RuptureMaria B Olsen, Gunn A Hildrestrand, Katja Scheffler, et al.
Journal of Medicinal Chemistry|October 1, 2004
Structure-activity relationship of heterobase-modified 2'-C-methyl ribonucleosides as inhibitors of hepatitis C virus RNA replicationAnne B Eldrup, Marija Prhavc, Jennifer Brooks, et al.
Bioorganic & Medicinal Chemistry Letters|October 23, 2012
Development of macrocyclic inhibitors of HCV NS3/4A protease with cyclic constrained P2-P4 linkersMichael T Rudd, Charles J McIntyre, Joseph J Romano, et al.
ACS Infectious Diseases|April 6, 2024
Mtb-Selective 5-Aminomethyl Oxazolidinone Prodrugs: Robust Potency and Potential LiabilitiesHelena I M Boshoff, Katherine Young, Yong-Mo Ahn, et al.
Atherosclerosis|March 14, 2021
DNA glycosylase Neil3 regulates vascular smooth muscle cell biology during atherosclerosis developmentAna Quiles-Jiménez, Ida Gregersen, Filip M Segers, et al.
Pageof 67

Showing results (641-650 of 665) with videos related to

Sort By:
Pageof 67
Bioorganic & Medicinal Chemistry Letters|April 9, 2015
Tricyclic 1,5-naphthyridinone oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents-SAR of left-hand-side moiety (Part-2)Sheo B Singh, David E Kaelin, Jin Wu, et al.
JACC. Basic to Translational Science|January 11, 2021
Absence of NLRP3 Inflammasome in Hematopoietic Cells Reduces Adverse Remodeling After Experimental Myocardial InfarctionMieke C Louwe, Maria B Olsen, Ole J Kaasbøll, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2012
MK-5172, a selective inhibitor of hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variantsVincenzo Summa, Steven W Ludmerer, John A McCauley, et al.
Journal of Medicinal Chemistry|February 19, 2010
Discovery of vaniprevir (MK-7009), a macrocyclic hepatitis C virus NS3/4a protease inhibitorJohn A McCauley, Charles J McIntyre, Michael T Rudd, et al.
Iscience|March 29, 2024
T cells with increased responsiveness cause obesity in mice without diet interventionIda Gregersen, Xiang Y Kong, Sander Kooijman, et al.
Cell Reports|January 5, 2017
NEIL3-Dependent Regulation of Cardiac Fibroblast Proliferation Prevents Myocardial RuptureMaria B Olsen, Gunn A Hildrestrand, Katja Scheffler, et al.
Journal of Medicinal Chemistry|October 1, 2004
Structure-activity relationship of heterobase-modified 2'-C-methyl ribonucleosides as inhibitors of hepatitis C virus RNA replicationAnne B Eldrup, Marija Prhavc, Jennifer Brooks, et al.
Bioorganic & Medicinal Chemistry Letters|October 23, 2012
Development of macrocyclic inhibitors of HCV NS3/4A protease with cyclic constrained P2-P4 linkersMichael T Rudd, Charles J McIntyre, Joseph J Romano, et al.
ACS Infectious Diseases|April 6, 2024
Mtb-Selective 5-Aminomethyl Oxazolidinone Prodrugs: Robust Potency and Potential LiabilitiesHelena I M Boshoff, Katherine Young, Yong-Mo Ahn, et al.
Atherosclerosis|March 14, 2021
DNA glycosylase Neil3 regulates vascular smooth muscle cell biology during atherosclerosis developmentAna Quiles-Jiménez, Ida Gregersen, Filip M Segers, et al.
Pageof 67